Advertisement
Advertisement

NPCE

NPCE logo

Neuropace, Inc. Common Stock

15.97
USD
Sponsored
+0.34
+2.16%
Jun 09, 13:49 UTC -4
Open

NPCE Earnings Reports

Positive Surprise Ratio

NPCE beat 14 of 21 last estimates.

67%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$23.13M
/
-$0.21
Implied change from Q1 26 (Revenue/ EPS)
+4.81%
/
+5.00%
Implied change from Q2 25 (Revenue/ EPS)
-1.66%
/
-19.23%

Neuropace, Inc. Common Stock earnings per share and revenue

On May 12, 2026, NPCE reported earnings of -0.20 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 14.75% surprise. Revenue reached 22.07 million, compared to an expected 22.08 million, with a -0.04% difference. The market reacted with a +0.06% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 23.13 million USD, implying an increase of 5.00% EPS, and increase of 4.81% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
FAQ
For Q1 2026, Neuropace, Inc. Common Stock reported EPS of -$0.20, beating estimates by 14.75%, and revenue of $22.07M, -0.04% below expectations.
The stock price moved up 0.06%, changed from $15.80 before the earnings release to $15.81 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 9 analysts, Neuropace, Inc. Common Stock is expected to report EPS of -$0.21 and revenue of $23.13M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement